Prostate cancer (PCa) is the most common worldwide diagnosed malignancy in male
population. The diagnosis, the identification of aggressive disease, and the post-treatment …

As metastasis is responsible for most cancer-related deaths, understanding the cellular and
molecular events that lead to cancer cell migration and invasion will certainly provide …

Abstract Background Abiraterone (Abi) is an androgen receptor signaling inhibitor that
significantly improves patients' life expectancy in metastatic prostate cancer (PCa). Despite …

Background Ocular neovascularization is a leading cause of blindness and visual
impairment. While intravitreal anti-VEGF agents can be effective, they do have several …

Prostate cancer (PCa) is one of the fatal illnesses among males globally. PCa-treatment
does not include radiotherapy. Chemotherapy eventually causes drug resistance, disease …

Abstract Fascin-1 (FSCN1) is recognized as an actin-binding protein, commonly exhibits up-
regulation in breast cancer (BC) and is crucial for tumor invasion and metastasis. The …

Human cancer statistics show that an increased incidence of urologic cancers such as
bladder cancer, prostate cancer, and renal cell carcinoma. Due to the lack of early markers …

Prostate-specific antigen (PSA) is a key biomarker commonly used to screen patients for
prostate cancer. A significant number of unnecessary biopsies are performed every year due …